SCHEMBL21067103

SCHEMBL21067103

O=C(O)NCc1ncc(F)cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGBL2 Q5U5Z8 1/20 0.40
APLNR P35414 1/20 0.39
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
TSHR P16473 1/20 0.35
CYP2C19 P33261 1/20 0.35
P4HTM Q9NXG6 1/20 0.35
NAMPT P43490 2/20 0.33
GAA P10253 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 2/20 0.32
RAB9A P51151 2/20 0.32
ALDH1A1 P00352 1/20 0.32
MLLT3 P42568 1/20 0.32
MLLT1 Q03111 1/20 0.32
PTGER4 P35408 1/20 0.32
SRC P12931 1/20 0.31
EGLN1 Q9GZT9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3633129 0.82 APLNR (0.46) AGBL2APLNRRAB9AALDH1A1NPC1
SCHEMBL17740013 0.80 MAOB (0.38) CYP1A2CYP2D6CYP2C9TSHRCYP2C19
SCHEMBL3716792 0.80 ALDH1A1 (0.38) CYP1A2CYP2D6CYP2C9TSHRCYP2C19
SCHEMBL21527961 0.78 TSHR (0.38) CYP1A2CYP2D6CYP2C9TSHRCYP2C19
SCHEMBL17057294 0.77 SMN1; SMN2 (0.42) CYP1A2CYP2D6CYP2C9TSHRCYP2C19
SCHEMBL4637326 0.76 KDM4E (0.41) GAAALDH1A1EGLN1L3MBTL1LMNA
SCHEMBL15173772 0.76 ADORA2A (0.44) P4HTMNAMPTKMT2ARAB9ASRC
SCHEMBL21106557 0.74 L3MBTL1 (0.43) CYP1A2NAMPTL3MBTL1LMNA
SCHEMBL16820345 0.72 ATM (0.42) CYP1A2CYP2D6CYP2C9TSHRCYP2C19
SCHEMBL17768550 0.72 AGBL2 (0.47) AGBL2KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3728249-A1 1H -PYRAZOLO[4,3-b ]PYRIDINES AS PDE1 INHIBITORS H. Lundbeck A/S (DK) 2020-10-28 EP disclosed
US-10766893-B2 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors H. LUNDBECK A/S (DK) 2020-09-08 US disclosed
US-20190194189-A1 1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS H. LUNDBECK A/S (DK) 2019-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10766893-B2 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors PDE12, PDE3B, PDE5A AGBL2 2461/4885APLNR 4150/4885CYP1A2 248/4885
US-20190194189-A1 1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS PDE12, PDE3B, PDE5A AGBL2 2461/4885APLNR 4150/4885CYP1A2 248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.